The THINK Study (Testing Hypoesthesia and the Incidence of Neurotrophic Keratopathy)
The study purpose is to evaluate corneal sensitivity in patients that have Stage 1 Neurotrphic Keratopathy (NK). Identifying patients with Stage 1 NK, may predict those who will in the future require rhNGF for optimal visual performance.
The COAT Trial: Cequa's Onset of Action Trial: an Investigation of CEQUA's Speed of Onset in Improving Ocular Surface Health in Dry Eye Patients
Cequa's Onset of Action Trial: an Investigation of CEQUA's Speed of Onset in Improving Ocular Surface Health in Dry Eye Patients
The Clareon PanOptix Trifocal IOL: A Study of Patient Satisfaction and Visual Performance
This will be a single arm, open-label, prospective study of patient-reported outcomes of patients with bilateral implantation of the Panoptix or Panoptix Toric implant.
100 项与 Research Insight Finland Oy 相关的临床结果
0 项与 Research Insight Finland Oy 相关的专利（医药）
100 项与 Research Insight Finland Oy 相关的药物交易
100 项与 Research Insight Finland Oy 相关的转化医学
